Patented Medicine Prices Review Board

The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by regulating the prices of patented medicines sold in Canada, and by reporting on pharmaceutical trends.

We are an independent quasi-judicial body that is part of the Health portfolio, and operate at arm’s-length from the Minister of Health.

Follow:

Twitter

We are in the process of moving our services and information to Canada.ca.

Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.

Latest news

Draft Guidelines Consultation until February 14, 2020

We are now consulting stakeholders and interested members of the public on the new Draft Guidelines following the amendments of the Patented Medicines Regulations.

Meds Entry Watch 2018

This is the fourth edition of the PMPRB’s Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries.

Patented Medicine Prices Review Board news

All news

Most requested

Contact us

More information for

Services and information

New patented medicines reported to the PMPRB

Search for new patented medicines reported to the PMPRB.

Regulatory process

Find information on the PMPRB’s regulatory and investigative process.

Find information on the PMPRB's statutory reporting requirements, guidance on filing requirements and deadlines, outreach presentations and recorded Webinar sessions, and answers to frequently-asked questions.

Reports and trends

Find information on key trends in sales and prices of patented medicines, and in pharmaceutical industry investments in research and development.

Voluntary Compliance Undertakings

See what patented medicines have been the subject of a pricing investigation that was resolued through a mutually acceptable pricing agreement between the PMPRB and the patentee.